Oregon Health & Science University, U.S.
Reports on Oregon Health & Science University, U.S., study findings provide new insights
Published in Hospital Law Weekly, November 30th, 2006
This trend article about Oregon Health & Science University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Patients with advanced soft tissue sarcoma did not exhibit objective response to O-6-benzylguanine (O-6-BG) and carmustine (BCNU) chemotherapy.
"Tumor resistance to alkylating agents such as BCNU has been found to be associated with intracellular expression of O-6-methylguanine-DNA methyltransferase (MGMT). Administration of O-6-BG, a substrate that inactivates MGMT, may help overcome...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2006-11-30)
More Articles from Hospital Law Weekly
- Business Update
Adherex enters partnership phase III trial of sodium thiosulfate to prevent hearing loss - Business Update
EVMS Health Services delivers personal health records - Market Analysis
Research and Markets offers Drager Medical Device Company report - Abdominal Aortic Aneurysm Epidemiology
Study results from Belfast City Hospital broaden understanding of abdominal aortic aneurysm epidemiology - Acute Myeloid Leukemia
Reports outline acute myeloid leukemia in children study findings from Children's Hospital, Department of Women's and Children's Health - Addiction Medicine
New data from Institute of Liver Studies illuminate research in addiction medicine - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
